Results 261 to 270 of about 270,728 (301)
Some of the next articles are maybe not open access.

The seesaw of CVD: Deaths down, costs up.

Managed care (Langhorne, Pa.), 2018
Coronary heart disease deaths will decline by 30% between 2010 and 2020 because of improvement in "cardiovascular health metrics" (avoidance of smoking, more physical activity, and so on). But this less-deadly era of CVD is going to be a more costly one, with direct medical costs of CVD more than doubling by 2030 to $918 billion from $396 billion in ...
openaire   +1 more source

In healthy older adults, aspirin did not affect disability-free survival or CVD but increased death and bleeding

Annals of Internal Medicine, 2019
Source Citation McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med.
openaire   +2 more sources

Seemingly healthy 71‐year‐old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT‐proBNP: Report from the ULSAM study

Scandinavian Journal of Clinical and Laboratory Investigation, 2009
Hypersensitive cardiac troponin I (cTnI) assays detect even minor elevations of cTnI. Previous findings identifying a group of seemingly healthy elderly men with very minor elevations of cTnI have shown that these men were at risk of premature cardiovascular death.To study the association between cTnI concentrations and cardiovascular risk factors and ...
Per, Venge   +2 more
openaire   +2 more sources

The role of ROS-induced pyroptosis in CVD

Frontiers in Cardiovascular Medicine, 2023
Zhen Tian
exaly  

The ever‐increasing importance of cancer as a leading cause of premature death worldwide

Cancer, 2021
Freddie Bray   +2 more
exaly  

Target and Cell Therapy for Atherosclerosis and CVD

International Journal of Molecular Sciences, 2023
Yuliya V Markina   +2 more
exaly  

Home - About - Disclaimer - Privacy